Earningsreport

Q1/2023 3/31/2023 EPS -0.400 ZacksConsensus -0.490 ActVsEst 0.090 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors